StockData
Onconetix, Inc. logo

Onconetix, Inc. (ONCO) stock

ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$3.00+0.09 (+3.09%)

Close on Nov 17, 2026Market cap $11.85MP/E –Yield –

Onconetix total assets

Total assets on the balance sheet at the end of each period.

Onconetix's total assets was $16.43M at Jun 30, 2026. For fiscal 2025 it was $24.93M, down 11.5% from the year before. The highest annual figure on record is $87.52M in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.93M-11.5%
FY2024Dec 31, 2024$28.18M-67.8%
FY2023Dec 31, 2023$87.52M+232.6%
FY2022Dec 31, 2022$26.31M+752.9%
FY2021Dec 31, 2021$3.08M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$16.43M-14.1%
Q1 FY2026Mar 31, 2026$14.83M-21.0%
Q4 FY2025Dec 31, 2025$24.93M-11.5%
Q3 FY2025Sep 30, 2025$19.68M-68.2%
Q2 FY2025Jun 30, 2025$19.12M-67.8%
Q1 FY2025Mar 31, 2025$18.78M-75.0%
Q4 FY2024Dec 31, 2024$28.18M-67.8%
Q3 FY2024Sep 30, 2024$61.92M+122.1%
Q2 FY2024Jun 30, 2024$59.46M+99.9%
Q1 FY2024Mar 31, 2024$75.03M+185.2%
Q4 FY2023Dec 31, 2023$87.52M+190.2%
Q3 FY2023Sep 30, 2023$27.88M+18.0%
Q2 FY2023Jun 30, 2023$29.75M+53.9%
Q4 FY2022Dec 31, 2022$26.31M+752.9%
Q3 FY2022Sep 30, 2022$30.16M–
Q2 FY2022Jun 30, 2022$23.63M–
Q1 FY2022Mar 31, 2022$19.34M–
Q4 FY2021Dec 31, 2021$3.08M–

More Onconetix figures

See a number that looks wrong?